Survodutide: nomenclature notes
A registry representation showing the main chain and the linker as separate sequences does not mean the substance is a mixture of two peptides. Survodutide and mazdutide are both GLP-1/glucagon dual agonists and are not interchangeable: they differ in main-chain sequence, nonstandard residue, conjugation position, linker and lipid. Shared receptor pharmacology is a classification, not chemical equivalence.
Mazdutide: nomenclature notes
The formula recorded here is the WHO-defined structure. PubChem's name-linked record reports C207H317N45O65, which differs by exactly one serine residue — C3H5NO2, 87.0320 Da. That is a difference in covalent peptide composition, not a salt form or a protonation state. PubChem CID 172871914 encodes the specified 34-residue peptide ending GGPSSG-NH2 with Aib2 and the Lys20-linked two-AEEA, gamma-L-glutamyl, C20-diacid modification, whereas CID 167312357 lacks one terminal-region serine. The discrepancy is evidence of a database conflict; it is not evidence about what any particular sample contains. Text extracted from WHO Proposed INN List 126 and Recommended List 88 gives Asp at position 9 in English, French and Spanish, but one indexed copy of List 88 gives Lys in French and Spanish; this record keeps Asp9, which its printed sequence also shows.